Fundz

Sava Technologies raises $36M in Series B led by Ascensia to develop glucose sensor technology eliminating fingerstick testing.

PRIVATEOct 09, 2026

Amount Raised

$36 Million

Round Type

Series B

LondonBiotechnologyHealth Care

Investors

Ascensia Diabetes Care

Description

Sava Technologies, a London-based medical device company, has secured $36 million in Series B funding led by Ascensia Diabetes Care, bringing total funding to $68 million. The capital will support development of a microsensor designed to eliminate the need for fingerstick glucose tests, with Ascensia partnering to commercialize and distribute the product in Europe. Founded in 2019 by bioengineers Renato Circi and Rafaël Michali, Sava aims to secure regulatory approval for insulin dosing without fingerstick checks within 18-24 months. The company's microsensors are approximately ten times smaller than conventional continuous glucose monitors, reducing skin disruption.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Sava Technologies that raised within 45 days of this round, from Fundz verified event records.

  • Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
  • Orakl Oncology raised $34M (Series A) on November 12, 2026.
  • Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
  • BioWraptor raised $1.5M (Pre-Seed) on November 12, 2026.
  • Neurosterix raised $105M (Series B) on November 11, 2026.
  • Kardi Ai raised $5.9M (Series A) on November 11, 2026.

Who to call at Sava Technologies, and when

A new round usually means Sava Technologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sava Technologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sava Technologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sava Technologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sava Technologies

Location

London, England, United Kingdom

About

Sava Technologies is a London-based MedTech startup focused on developing real-time molecular health monitoring solutions. Founded in 2019 by bioengineers from Imperial College London, the company aims to build the technological foundation for preventative and personalised healthcare. They have developed a multi-molecule biosensor that detects biomarkers just beneath the skin, leading to innovations like a pain-free continuous glucose monitor. Their technology has shown promise in clinical trials, offering reliable glucose readings for extended wear.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sava Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Sava Technologies's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Sava Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.